The following information comes from DailyMed, an FDA label information provider.
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In all controlled and uncontrolled trials across various patient populations during the premarketing development of LYRICA, more than 10,000 patients have received LYRICA. Approximately 5000 patients were treated for 6 months or more, over 3100 patients were treated for 1 year or longer, and over 1400 patients were treated for at least 2 years
DailyMed also states the following side effects may occur with pregabalin:
- Face swelling
- Breathing difficulties
- Suicidal thinking/behavior
- Weight gain
- Visual disturbances
- Respiratory depression
Please note this list is not exhaustive, and it is critical that you contact your prescribing physician or a pharmacist if you experience any side effects.